Compositions and Methods for Diagnosing and Treating Diseases and Disorders Associated With D-DT
AssigneeYale University
InventorsRichard J. Bucala, Lawrence H. Young
Life of this patent
Estimating the term…
Abstract
The present invention relates to the discovery that altered levels of D-DT (also known as MIF-2) are associated with disorders and diseases. Thus, the present invention relates to compositions and methods useful of the assessment, diagnosis, characterization, prevention and treatment of disorders and diseases associated with an elevated level of D-DT. The present invention also relates to compositions and methods useful of the assessment, diagnosis, characterization, prevention and treatment of disorders and diseases associated with a reduced level of D-DT.
Claims36
A method of diagnosing a disease or disorder in a subject in need thereof, the method comprising:
- a. determining the level of D-DT in a biological sample from the subject,
- b. comparing the level of D-DT in the biological sample with a comparator control, and
- diagnosing the subject with a disease or disorder when the level of D-DT in the biological sample is different than the level of D-DT of the comparator control.
(canceled)
A composition comprising a D-DT inhibitor.
A method of treating or preventing a disease or disorder in a subject in need thereof, the method comprising:
- administering to the subject a therapeutically effective amount of a composition comprising a D-DT inhibitor.
33-44. (canceled)
A composition comprising a D-DT activator.
47-63. (canceled)
Dependencies are inferred from the claim text.